Genome Editing Dilemma: Navigating Dual-Use Potential and Charting the Path Forward

Author:

Badea Ana RuxandraORCID,Feeney Oliver

Abstract

AbstractContemporary genome editing techniques have made genomic intervention—from microorganism to human—more accessible, easier to use, and more accurate than previous methods. We argue that, notwithstanding its merits in treating and preventing disease in humans, genome editing represents a potential threat for domestic and international security, requiring an integrated approach in regulating, detecting, preventing, and mitigating the risk of its use for malicious purposes. Despite the global regulatory ambitions of the 2021 WHO framework, we see insufficient attention given to the future prospect of dual-use genomic technology. Drawing parallels with the nuclear field, we suggest tentative practical steps for a way forward in dealing with genome editing technologies, such as: 1) adapting national (bio)security and defence strategies to include genome editing as a possible threat (with conceivable WMD potential); 2) enhancing the international dialogue on genome editing and raising the issue at the highest level; 3) working towards a global, legally binding verification mechanism; 4) tracking genome editing technologies.

Publisher

Springer Science and Business Media LLC

Reference74 articles.

1. Barrie, R. 2024. CRISPR gene therapy Casgevy secures approval in Europe. Pharmaceutical Technology. https://www.pharmaceutical-technology.com/news/crispr-gene-therapy-casgevy-secures-approval-in-europe/. Accessed February 28, 2024.

2. Betapudi, V., R. Goswami, L. Silayeva, D.M. Doctor, and N. Chilukuri. 2020. Gene therapy delivering a paraoxonase 1 variant offers long-term prophylactic protection against nerve agents in mice. Science Translational Medicine 12(527): eaay0356.

3. Chun, M. 2023. Responding to the comeback of He Jiankui, “the CRISPR baby scientist”: lessons from criminal justice theory. Bill of Health—Harvard Law School, March 8. https://blog.petrieflom.law.harvard.edu/2023/03/08/he-jiankui-crispr-baby-scientist-comeback/. Accessed May 24, 2023.

4. Church, G. 2023. Project “Genome and microbiome modification for space”. Harvard Molecular Technologies. https://arep.med.harvard.edu/gmc/protect.html. Accessed February 5, 2024.

5. Cohen, J., and N. Desai. 2019. With CRISPR revolution, China becomes a world leader in genome editing. Science, August 2. https://www.science.org/content/article/its-crispr-revolution-china-becomes-world-leader-genome-editing. Accessed October 28, 2022.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3